![Kirstin N. Anderson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kirstin N. Anderson
Plus aucun poste en cours
Profil
Kirstin N.
Anderson worked as a Chief Financial Officer at ClearStream Investments LLC.
Prior to that, she was an Audit Consultant at Deloitte & Touche LLP and a Staff Associate at Arthur Anderson & Co. She also worked as an Assistant Controller at Sesen Bio, Inc. from 2016 to 2018.
Anderson received a graduate degree from The University of Colorado in 2000 and an undergraduate degree from the University of Maryland.
Anciens postes connus de Kirstin N. Anderson
| Sociétés | Poste | Fin |
|---|---|---|
ClearStream Investments LLC
 ClearStream Investments LLC Investment ManagersFinance ClearStream Investments employs a non-traditional, global investment approach that is based on the application of optimal pricing principles to investment management. The firm's models are not dependent on fundamental data used in traditional methods to value equity, fixed-income and other asset classes. ClearStream's investment universe is comprised primarily of US-listed ETFs and index funds representing global capital markets including equities, commodities, interest rates, fixed-income and currencies. ClearStream's quantitative models seek to identify pricing anomalies that predict the directionality of the securities in which they invest. The firm deals primarily in country and sector ETFs which typically make up 80% of their portfolio and incorporate both equity and non-equity markets. The remainder of ClearStream's portfolio is usually invested in commodities, fixed-income securities and foreign exchange. | Directeur Financier/CFO | 31/05/2011 |
Deloitte & Touche LLP
 Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Corporate Officer/Principal | 01/01/2006 |
| CARISMA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 22/04/2021 |
Arthur Anderson & Co. | Corporate Officer/Principal | - |
Formation de Kirstin N. Anderson
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
100
+
Relations au 1er degré
6
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
ClearStream Investments LLC
ClearStream Investments LLC Investment ManagersFinance ClearStream Investments employs a non-traditional, global investment approach that is based on the application of optimal pricing principles to investment management. The firm's models are not dependent on fundamental data used in traditional methods to value equity, fixed-income and other asset classes. ClearStream's investment universe is comprised primarily of US-listed ETFs and index funds representing global capital markets including equities, commodities, interest rates, fixed-income and currencies. ClearStream's quantitative models seek to identify pricing anomalies that predict the directionality of the securities in which they invest. The firm deals primarily in country and sector ETFs which typically make up 80% of their portfolio and incorporate both equity and non-equity markets. The remainder of ClearStream's portfolio is usually invested in commodities, fixed-income securities and foreign exchange. | Finance |
Deloitte & Touche LLP
Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, financial advisory and tax consulting services | Commercial Services |
The University of Colorado
 The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
 University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arthur Anderson & Co. | |
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops protein therapeutics to treat eye diseases | Health Technology |
